Emma C. de Moel

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Emma C. de Moel, Elisa A. Rozeman, Ellen Kapiteijn et al. · Cancer Immunology Research · 2018 · 195 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>N</i>‐Linked Glycans in the Variable Domain of IgG Anti–Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis

Lise Hafkenscheid, Emma C. de Moel, Irene Smolik et al. · Arthritis & Rheumatology · 2019 · 115 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Emma C. de Moel, V. Derksen, Leendert A. Trouw et al. · Arthritis Research & Therapy · 2019 · 61 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

Emma C. de Moel, V. Derksen, Gerrie Stoeken et al. · Arthritis Research & Therapy · 2018 · 52 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis

Josephine A. M. P. Amkreutz, Emma C. de Moel, Lisa Theander et al. · Arthritis & Rheumatology · 2020 · 33 citations · Full text

Medicine, Immunology, Internal Medicine +17